Next-generation sequencing-based test for detecting somatic mutations in solid tumors. Achieved perfect scores in national quality control assessments and is used for tumor classification and treatment selection.
Manufactured by
China
Shanghai Biotecan Pharmaceuticals Co., Ltd., established in 2008, is a leading precision medicine enterprise in China with 17 subsidiaries. The company maintains strict quality management following GLP standards and consistently achieves perfect scores in CAP proficiency testing. Specializing in molecular diagnostics and medical big data analytics, Biotecan provides precision medicine services using advanced technologies.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
LYTECH
Serbia · 2 relevant products
guangzhou biotron technolongy co.,ltd
China · 2 relevant products
GeneCker Co., Ltd.
South Korea · 1 relevant product
54 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →15 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 94 closest product alternatives
LYTECH · Serbia
A diagnostic test for quantitative detection and analysis of somatic mutations in human samples. The SMuQ test provides quantitative measurement of somatic mutation burden and is part of LYTECH's human genetics diagnostic offerings.
guangzhou biotron technolongy co.,ltd · China
Molecular diagnostic system tracking circulating tumor cell dynamics and nucleic acid markers to evaluate cancer treatment efficacy and guide therapeutic decisions.
GeneCker Co., Ltd. · South Korea
Molecular diagnostic test using CRISPR/Cas9 technology to identify and amplify mutant DNA sequences in patient samples. Provides standardized detection and quantification of cancer-related genetic mutations.
91 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products